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Editors’ Note: In reference to “Low-frequency stimulation
of STN-DBS reduces aspiration and freezing of gait in
patients with PD,” Dr. Sidiropoulos suggests several
avenues of further investigation including low-frequency
stimulation to treat dysarthria, the effects of different
stimulation location and parameters, and the duration of
clinical benefit. Authors Xie et al. respond. Drs. Lattanzi
and Silvestrini and author Anderson discuss intensive
blood pressure lowering and blood pressure variability in
the acute management of intracerebral hemorrhage.
—Megan Alcauskas, MD, and Robert C. Griggs, MD
LOW-FREQUENCY STIMULATION OF STN-DBS
REDUCES ASPIRATION AND FREEZING OF GAIT
IN PATIENTS WITH PD
Christos Sidiropoulos, Detroit: I thank Xie et al.1 for
their study using low-frequency stimulation (LFS) of the
subthalamic nucleus to address axial symptoms in
advanced Parkinson disease (PD). The authors objectively
assessed improvement in dysphagia with surprisingly
robust results. It would be interesting to investigate reso-
lution of dysarthria with LFS. In addition, duration as a
clinical benefit should have been considered since other
studies have indicated loss of improvement over time in
LFS.2,3 Valid, long-term benefits will need to be assessed.
In another study evaluating LFS,4 the authors used
more ventral contacts, which merits further investiga-
tion. In most LFS studies, investigators tried to adjust
voltage for the same total electrical energy delivered,
which the authors did not do. The authors’ chart shows
that 130Hz directly worsened freezing of gait and other
axial symptoms since the deep brain stimulation (DBS)
“off” condition was better than the 130 Hz condition.
In addition, their DBS “on” medication scores using
130 Hz were quite high, raising questions about how
efficient patients were truly programmed.
The authors also stated that all but one patient
were on monopolar stimulation. Did the authors
attempt other programming modalities such as bipo-
lar to reduce current spread or interleaving?
Author Response: Tao Xie, Julie Vigil, Ellen
MacCracken, Peter Warnke, Chicago; Un J. Kang,
New York: We thank Dr. Sidiropoulos for raising
important points related to the outcomes of our study.1
We appreciate the suggestion to examine the outcome
of dysarthria with LFS. One study found LFS subtha-
lamic nucleus beneficial for dysarthropneumophonia.5
We agree that assessing longer-term outcome of LFS
on swallowing and freezing of gait is important.
Although other studies reported the loss of
improvement over time on LFS,2,3 they used a differ-
ent frequency stimulation, patient population, and
design, and no radiographic swallowing assessment.
However, the persistent benefit of 60 Hz stimulation
on freezing of gait at medication “off” state was re-
ported by another group.6 We are in the process of
conducting a long-term follow-up study.
We agree that stimulation location and parameters
should be explored further. We had a small proportion
of patients with ventral contacts and bipolar stimula-
tion and cannot comment on these variables. We hope
these findings stimulate others to explore further opti-
mization of DBS parameters for refractory symptoms.
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OPTIMAL ACHIEVED BLOOD PRESSURE IN
ACUTE INTRACEREBRAL HEMORRHAGE:
INTERACT2
Simona Lattanzi, Mauro Silvestrini, Ancona, Italy:
Arima et al.1 addressed the optimal management of
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blood pressure (BP) in the acute phase of intracerebral
hemorrhage (ICH).1 First, they showed the benefit of
intensive BP lowering on physical function across a
wide range of baseline systolic BP (SBP). Although
the point-estimated odds ratios favored an intensive
regimen across all 5 subgroups identified according to
baseline BP, the confidence intervals embraced the
values of no difference between per-protocol intensive
and guideline-recommended treatments. Further
investigation is needed to better define the real effect
sizes of the intervention.
Second, a SBP range of 130–139 mm Hg is ben-
eficial. Since lowering BP influences and increases BP
variability (BPV) and high variability in BP represents
a strong predictor of poor functional outcome after
ICH,2 a combined analysis—which also includes the
effects of BPV—may indicate the best strategy to
achieve target BP values.
Author Response: Craig S. Anderson, Camper-
down, Australia: Drs. Lattanzi and Silvestrini high-
lighted the modest potential benefits of early intensive
BP lowering in acute intracerebral hemorrhage, but over-
looked the consistency of no harm from the treatment.
The consistency of positive outcomes of this treatment
according to subgroup analysis in this article—and those
of BP variability in the full cohort—adds further weight
to the positive findings, which just missed statistical sig-
nificance on the primary outcome due to reduced power.
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